Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort

Human epidermal growth factor receptor 2 (HER2)-targeting therapies have become crucial in the management of HER2-positive breast cancer. Trastuzumab emtansine (T-DM1) is a microtubule inhibitor and HER2-targeted antibody conjugate. T-DM1 resistance is most likely influenced by factors involved in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Akyildiz, Arif, Guven, Deniz Can, Yildirim, Hasan Cagri, Ismayilov, Rashad, Yilmaz, Feride, Tatar, Omer Denizhan, Chalabiyev, Elvin, Kus, Fatih, Yalcin, Suayib, Aksoy, Sercan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158859/
https://www.ncbi.nlm.nih.gov/pubmed/37145008
http://dx.doi.org/10.1097/MD.0000000000033677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158859/
https://www.ncbi.nlm.nih.gov/pubmed/37145008
http://dx.doi.org/10.1097/MD.0000000000033677

Ejemplares similares